An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor ...
Feb 26, 2020
0
1
The makeup of our microbiomes—the unique communities of bacteria, viruses and other microbes that live in and on us—have been linked, with varying degrees of evidence, to everything from inflammatory bowel disease to ...
Feb 26, 2020
0
98
Curtin University researchers have developed tiny capsules that are able to effectively target the liver and pancreas reducing the inflammatory effects of type two diabetes.
Jan 13, 2020
0
110
Could bile acids—the fat-dissolving juices churned out by the liver and gallbladder—also play a role in immunity and inflammation?
Jan 3, 2020
0
915
A new study led by researchers at Baylor College of Medicine and published in the Proceedings of the National Academy of Sciences reveals that human noroviruses, the leading viral cause of foodborne illness and acute diarrhea ...
Dec 31, 2019
0
298
Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the U.S., currently lack an approved drug therapy, but this may soon change. A large Phase III clinical ...
Dec 5, 2019
0
6
Compounds from hops may combat metabolic syndrome by changing the gut microbiome and altering the metabolism of acids produced in the liver, new research at Oregon State University suggests.
Nov 25, 2019
0
398
In a new study published 29th August in PLOS Genetics, Federico Rey of the University of Wisconsin—Madison and colleagues identified genetic variants in mice that impact the levels of different bile acids as well as the ...
Aug 29, 2019
0
28
Researchers from The Westmead Institute for Medical Research (WIMR) have discovered how fatty liver disease develops in lean people, aiding the development of potential treatments for these patients.
Aug 26, 2019
0
160
A team led by Michael Trauner at MedUni Vienna's Division of Gastroenterology and Hepatology demonstrated the beneficial effect of synthetically produced bile acid with the active agent nor-ursodeoxycholic acid (nor-urso) ...
Jul 29, 2019
0
2
